LEADER 01208nam  2200337   450 
001 9910693564903321
005 20221104172921.0
035   $a(CKB)3450000000002406
035   $a(NjHacI)993450000000002406
035   $a(EXLCZ)993450000000002406
100   $a20221104d1999      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aRelative Effectiveness and Cost-Effectiveness of Methods of Androgen Suppression in the Treatment of Advanced Prostate Cancer /$fNaomi Aronson [and eleven others]
210  1$aRockville, Maryland :$cAgency for Healthcare Research and Quality (US),$d[1999]
210  4$dİ1999
215   $a1 online resource $cillustrations
320   $aIncludes bibliographical references.
606   $aProstate$xCancer
615  0$aProstate$xCancer.
676   $a616.99463
700   $aAronson$b Naomi$01351277
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910693564903321
996   $aRelative Effectiveness and Cost-Effectiveness of Methods of Androgen Suppression in the Treatment of Advanced Prostate Cancer$93092729
997   $aUNINA

LEADER 00619nam0-22002411i-450 
001 990002705170403321
005 20231109153749.0
035   $a000270517
035   $aFED01000270517
035   $a(Aleph)000270517FED01
100   $a20000920d1929----km-y0itay50------ba
101 0 $ager
102   $aDE
200 1 $a<<Der >>kosteningenieur.$fvon Zeidler
210   $aBerlin$cVDI$d1929
700  1$aZeidler,$bEberhard$040565
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990002705170403321
952   $aC3-P04-16-RA$bs.i$fECA
959   $aECA
996   $aKosteningenieur$9426670
997   $aUNINA